VFA
Values First Advisors’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
18,449
+1,804
| +11% | +$53.3K | 0.3% | 98 |
|
|
2025
Q1 | $497K | Sell |
16,645
-261
| -2% | -$7.79K | 0.29% | 95 |
|
|
2024
Q4 | $484K | Sell |
16,906
-1,506
| -8% | -$43.1K | 0.27% | 97 |
|
|
2024
Q3 | $711K | Buy |
18,412
+1,419
| +8% | +$54.8K | 0.39% | 69 |
|
|
2024
Q2 | $547K | Buy |
16,993
+1,057
| +7% | +$34K | 0.33% | 78 |
|
|
2024
Q1 | $619K | Sell |
15,936
-17,929
| -53% | -$696K | 0.36% | 78 |
|
|
2023
Q4 | $1.04M | Sell |
33,865
-9,642
| -22% | -$297K | 0.63% | 47 |
|
|
2023
Q3 | $972K | Buy |
43,507
+6,557
| +18% | +$147K | 0.63% | 46 |
|
|
2023
Q2 | $794K | Buy |
36,950
+7,325
| +25% | +$157K | 0.48% | 62 |
|
|
2023
Q1 | $711K | Sell |
29,625
-18,003
| -38% | -$432K | 0.45% | 65 |
|
|
2022
Q4 | $1.1M | Buy |
47,628
+2,193
| +5% | +$50.9K | 0.77% | 44 |
|
|
2022
Q3 | $728K | Sell |
45,435
-2,652
| -6% | -$42.5K | 0.52% | 64 |
|
|
2022
Q2 | $852K | Buy |
48,087
+2,474
| +5% | +$43.8K | 0.61% | 54 |
|
|
2022
Q1 | $929K | Buy |
45,613
+3,301
| +8% | +$67.2K | 0.59% | 54 |
|
|
2021
Q4 | $790K | Buy |
42,312
+539
| +1% | +$10.1K | 0.47% | 70 |
|
|
2021
Q3 | $825K | Buy |
41,773
+4,551
| +12% | +$89.9K | 0.53% | 63 |
|
|
2021
Q2 | $880K | Buy |
37,222
+4,325
| +13% | +$102K | 0.6% | 58 |
|
|
2021
Q1 | $780K | Sell |
32,897
-6,142
| -16% | -$146K | 0.58% | 62 |
|
|
2020
Q4 | $782K | Buy |
39,039
+7,798
| +25% | +$156K | 0.62% | 57 |
|
|
2020
Q3 | $650K | Buy |
31,241
+6,932
| +29% | +$144K | 0.6% | 58 |
|
|
2020
Q2 | $425K | Sell |
24,309
-36
| -0.1% | -$629 | 0.42% | 82 |
|
|
2020
Q1 | $398K | Sell |
24,345
-15,254
| -39% | -$249K | 0.48% | 68 |
|
|
2019
Q4 | $815K | Buy |
+39,599
| New | +$815K | 0.79% | 49 |
|